Evidence map›Paper›PMID 40060399›Full record

ArticlebioRxiv : the preprint server for biology2025

Distinct roles for thymic stromal lymphopoietin (TSLP) and IL-33 in experimental eosinophilic esophagitis.

Anish Dsilva, Ariel Wagner, Michal Itan, Natalie Rhone, Shmulik Avlas, Yaara Gordon, Natalie Davidian, Shraddha Sharma, Elizaveta Razravina, Israel Zan-Bar and 7 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Anish DsilvaDepartment of Clinical Microbiology and Immunology, Faculty of Medical and Health Sciences, Tel-Aviv University, Israel.
Ariel WagnerDepartment of Clinical Microbiology and Immunology, Faculty of Medical and Health Sciences, Tel-Aviv University, Israel.
Michal ItanDepartment of Clinical Microbiology and Immunology, Faculty of Medical and Health Sciences, Tel-Aviv University, Israel.
Natalie RhoneDepartment of Clinical Microbiology and Immunology, Faculty of Medical and Health Sciences, Tel-Aviv University, Israel.
Shmulik AvlasDepartment of Clinical Microbiology and Immunology, Faculty of Medical and Health Sciences, Tel-Aviv University, Israel.
Yaara GordonDepartment of Clinical Microbiology and Immunology, Faculty of Medical and Health Sciences, Tel-Aviv University, Israel.
Natalie DavidianDepartment of Clinical Microbiology and Immunology, Faculty of Medical and Health Sciences, Tel-Aviv University, Israel.
Shraddha SharmaDepartment of Clinical Microbiology and Immunology, Faculty of Medical and Health Sciences, Tel-Aviv University, Israel.
Elizaveta RazravinaDepartment of Clinical Microbiology and Immunology, Faculty of Medical and Health Sciences, Tel-Aviv University, Israel.
Israel Zan-BarDepartment of Clinical Microbiology and Immunology, Faculty of Medical and Health Sciences, Tel-Aviv University, Israel.
Jane R ParnesEarly Development, Amgen, Thousand Oaks, California, USA.
Kevin S GorskiClinical Biomarkers and Diagnostics, Amgen, South San Francisco, California, USA.
Joseph D SherrillTranslational Science and Experimental Medicine, Research & Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
Chen VarolDepartment of Clinical Microbiology and Immunology, Faculty of Medical and Health Sciences, Tel-Aviv University, Israel.
Steven F ZieglerCenter for Fundamental Immunology, Benaroya Research Institute, Seattle, WA, USA.
Marc E RothenbergDivision of Allergy/Immunology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Ariel MunitzDepartment of Clinical Microbiology and Immunology, Faculty of Medical and Health Sciences, Tel-Aviv University, Israel.ORCID 0000-0003-1626-3019

Funding

TSLP, IL-9-producing mucosal mast cells, and allergic inflammationU19AI070235 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI Gurjit K. Khurana Hershey · 2006 to 2026
$31.3M
Stem Cell/Organoid and Genome Editing CoreP30DK078392 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI LEE ARMISTEAD DENSON · 2007 to 2026
$24.4M
Genetic and Immunological Dissection of Eosinophilic EsophagitisR01AI124355 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI Marc E. Rothenberg · 2015 to 2026
$5.9M
Regulation of Gastrointestinal EosinophilsR37AI045898 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI ROTHENBERG, MARC E. · 2010 to 2019
$3.6M
NIAID NIH HHS R01 AI124355NIAID NIH HHS R37 AI045898NIAID NIH HHS U19 AI070235NIDDK NIH HHS P30 DK078392
6 · The paper itself

Abstract

Rationale: Thymic stromal lymphopoietin (TSLP) and IL-33 are alarmins implicated in EoE pathogenesis by activating multiple cells including mast cells (MCs). Whether TSLP or IL-33 have a role in EoE and whether their activities are distinct requires further investigation. Methods: Experimental EoE was induced in wild type (WT) Results: TSLP and IL-33 were overexpressed in human and experimental EoE. Human and mouse esophageal MCs displayed the highest level of Conclusion: TSLP and IL-33 have non-redundant functions in experimental EoE. This study highlights TSLP as an upstream regulator of IL-13 and a potential therapeutic target for EoE.

Indexed as

AllergyEosinophilic EsophagitisIL-33TSLP

Identifiers

PMID40060399
PMCPMC11888463

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.